UPDATE: Stifel Nicolaus Initiates DENTSPLY International at Holdon Generic Implant Risk
Stifel Nicolaus initiated coverage on DENTSPLY International (NASDAQ: XRAY) with a Hold rating.
Stifel Nicolaus noted, "Diligence points to concerns in the dental implant market, a potential for moderating growth in endodontics, and doctor checks that reveal slightly deteriorating U.S. dental patient volume. Collectively, the implant and endodontic specialty divisions as well as the consumables businesses (preventives and restoratives) account for approximately 70% of DENTSPLY's total revenue (x-precious metals). Despite the stock's current NTM P/E multiple, which reflects a slight discount to its historical average, our work in these various business units keeps us on the sidelines."
DENTSPLY International closed at $39.66 on Wednesday.
Latest Ratings for XRAY
|Feb 2017||Barrington Research||Downgrades||Outperform||Market Perform|
|Feb 2017||Stifel Nicolaus||Upgrades||Hold||Buy|
|Dec 2016||Barrington Research||Upgrades||Market Perform||Outperform|
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.